These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 33832212)
21. Intestinal Flora is a Key Factor in Insulin Resistance and Contributes to the Development of Polycystic Ovary Syndrome. Yang YL; Zhou WW; Wu S; Tang WL; Wang ZW; Zhou ZY; Li ZW; Huang QF; He Y; Zhou HW Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34145455 [TBL] [Abstract][Full Text] [Related]
22. Gut microbiota in chronic kidney disease. Cigarran Guldris S; González Parra E; Cases Amenós A Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986 [TBL] [Abstract][Full Text] [Related]
23. Role of Intestinal Microbiome in Lipid and Glucose Metabolism in Diabetes Mellitus. van Olden C; Groen AK; Nieuwdorp M Clin Ther; 2015 Jun; 37(6):1172-7. PubMed ID: 25922340 [TBL] [Abstract][Full Text] [Related]
24. [Studies on protein metabolism in renal insufficiency]. MUETING D; SHIVARAM KN Verh Dtsch Ges Inn Med; 1959; 65():635-9. PubMed ID: 14425010 [No Abstract] [Full Text] [Related]
25. Insulin resistance in chronic uremia. Guarnieri G; Zanetti M; Vinci P; Cattin MR; Barazzoni R J Ren Nutr; 2009 Jan; 19(1):20-4. PubMed ID: 19121765 [TBL] [Abstract][Full Text] [Related]
26. Xuan W; Ou Y; Chen W; Huang L; Wen C; Huang G; Tang W; Zeng D; Huang S; Xiao L; Li Z Br J Biomed Sci; 2023; 80():10794. PubMed ID: 37025162 [No Abstract] [Full Text] [Related]
27. Chrysin Improves Glucose and Lipid Metabolism Disorders by Regulating the AMPK/PI3K/AKT Signaling Pathway in Insulin-Resistant HepG2 Cells and HFD/STZ-Induced C57BL/6J Mice. Zhou YJ; Xu N; Zhang XC; Zhu YY; Liu SW; Chang YN J Agric Food Chem; 2021 May; 69(20):5618-5627. PubMed ID: 33979145 [TBL] [Abstract][Full Text] [Related]
28. Insights into a Possible Mechanism Underlying the Connection of Carbendazim-Induced Lipid Metabolism Disorder and Gut Microbiota Dysbiosis in Mice. Jin C; Zeng Z; Wang C; Luo T; Wang S; Zhou J; Ni Y; Fu Z; Jin Y Toxicol Sci; 2018 Dec; 166(2):382-393. PubMed ID: 30496565 [TBL] [Abstract][Full Text] [Related]
29. The Ameliorative Effect of COST on Diet-Induced Lipid Metabolism Disorders by Regulating Intestinal Microbiota. You H; Deng X; Bai Y; He J; Cao H; Che Q; Guo J; Su Z Mar Drugs; 2022 Jul; 20(7):. PubMed ID: 35877737 [TBL] [Abstract][Full Text] [Related]
30. Insulin secretion in uremia: effect of parathyroid hormone and vitamin D metabolites. Mak RH Kidney Int Suppl; 1989 Nov; 27():S227-30. PubMed ID: 2699996 [TBL] [Abstract][Full Text] [Related]
31. Effect of acute uremia on various aspects of carbohydrate metabolism in dogs. Swenson RS; Peterson DT; Eshleman M; Reaven GM Kidney Int; 1973 Oct; 4(4):267-72. PubMed ID: 4752170 [No Abstract] [Full Text] [Related]
35. Antibiotics-mediated intestinal microbiome perturbation aggravates tacrolimus-induced glucose disorders in mice. Han Y; Jiang X; Ling Q; Wu L; Wu P; Tang R; Xu X; Yang M; Zhang L; Zhu W; Wang B; Li L Front Med; 2019 Aug; 13(4):471-481. PubMed ID: 31054103 [TBL] [Abstract][Full Text] [Related]
36. Chronic kidney disease and the gut microbiome. Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840 [TBL] [Abstract][Full Text] [Related]
37. Insulin resistance in uremia. Characterization of insulin action, binding, and processing in isolated hepatocytes from chronic uremic rats. Kauffman JM; Caro JF J Clin Invest; 1983 Mar; 71(3):698-708. PubMed ID: 6338044 [TBL] [Abstract][Full Text] [Related]
38. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. Ramezani A; Massy ZA; Meijers B; Evenepoel P; Vanholder R; Raj DS Am J Kidney Dis; 2016 Mar; 67(3):483-98. PubMed ID: 26590448 [TBL] [Abstract][Full Text] [Related]